A phase 2, multicenter, clinical trial of CPX-351 in older patients with secondary or high-risk acute myeloid leukemia: PETHEMA-LAMVYX

  1. Rodríguez-Arbolí, E.
  2. Rodríguez-Veiga, R.
  3. Soria-Saldise, E.
  4. Bergua, J.M.
  5. Caballero-Velázquez, T.
  6. Arnán, M.
  7. Vives, S.
  8. Serrano, J.
  9. Bernal, T.
  10. Martínez-Sánchez, P.
  11. Tormo, M.
  12. Rodríguez-Medina, C.
  13. Herrera-Puente, P.
  14. Lavilla-Rubira, E.
  15. Boluda, B.
  16. Acuña-Cruz, E.
  17. Cano, I.
  18. Cáceres, S.
  19. Ballesteros, J.
  20. Falantes, J.
  21. Martínez-Cuadrón, D.
  22. Pérez-Simón, J.A.
  23. Montesinos, P.
Journal:
Cancer

ISSN: 1097-0142,  0008-543X

Year of publication: 2024

Type: Article

DOI: 10.1002/CNCR.35618 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus